Fuzzy Panda Research announced that it is short Tenet Healthcare (THC). The firm’s analysis shows Tenet is “back at it again,” appearing to be “doing the same things. And they have added a couple of new tricks like creatively reallocating indirect corporate costs to hospitals to pad their Medicare & Medicaid reimbursements, and management’s pockets.” The firm says it has discovered over 50 False Claims Act lawsuits against Tenet and its hospitals, settling fines for more than $2.5B.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THC:
- RBC a buyer of hospital stocks on White House memo selloff
- HCA Healthcare price target raised to $410 from $355 at Morgan Stanley
- Tenet Healthcare price target raised to $210 from $175 at Morgan Stanley
- Tenet Healthcare Appoints Lisa Y. Foo as COO
- 3 Undervalued Stocks to Buy Now, 6/5/2025, According to Analysts